{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Leurubicin",
  "nciThesaurus": {
    "casRegistry": "70774-25-3",
    "chebiId": "",
    "chemicalFormula": "C33H40N2O12",
    "definition": "An N-L-leucyl prodrug of the anthracycline doxorubicin, with antineoplastic activity. Leurubicin is converted to its active form doxorubicin in or on tumor cells by hydrolytic enzymes.",
    "fdaUniiCode": "1Z20MGK851",
    "identifier": "C81421",
    "preferredName": "Leurubicin",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1594"
    ],
    "synonyms": [
      "LEURUBICIN",
      "Leurubicin"
    ]
  }
}